Cyclo Therapeutics (CYTH) News Today $1.15 +0.03 (+2.68%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period June 25, 2024 | businesswire.comCyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024May 30, 2024 | businesswire.comCyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1May 16, 2024 | investorplace.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024May 16, 2024 | businesswire.comCyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 2, 2024 | msn.comHC Wainwright & Co. Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationApril 23, 2024 | nasdaq.comAscendiant Capital Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy RecommendationApril 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)April 10, 2024 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics StockMarch 19, 2024 | investorplace.comCYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023March 18, 2024 | businesswire.comCyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateMarch 14, 2024 | finance.yahoo.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s DiseaseMarch 14, 2024 | businesswire.comCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's DiseaseFebruary 2, 2024 | finance.yahoo.comCyclo Therapeutics, Inc. (CYTH)January 29, 2024 | markets.businessinsider.comCyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's DiseaseJanuary 29, 2024 | finance.yahoo.comCyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark OfficeJanuary 3, 2024 | morningstar.comCyclo Therapeutics Inc CYTHDecember 28, 2023 | msn.comCytosorbents, Cyclo Therapeutics among healthcare moversDecember 18, 2023 | finance.yahoo.comCyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1December 14, 2023 | finance.yahoo.comRafael Holdings Reports First Quarter Fiscal 2024 Financial ResultsNovember 29, 2023 | businesswire.comAPPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied ...November 21, 2023 | finance.yahoo.comCyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024November 15, 2023 | msn.comCyclo Therapeutics reports Q3 resultsNovember 15, 2023 | finance.yahoo.comCyclo Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | seekingalpha.comWISH, REAL and PIXY among mid-day moversNovember 2, 2023 | finance.yahoo.comSeveral Insiders Invested In Cyclo Therapeutics Flagging Positive NewsOctober 30, 2023 | finance.yahoo.comRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial ResultsOctober 23, 2023 | finance.yahoo.comCyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 MillionOctober 5, 2023 | finance.yahoo.comCyclo Therapeutics to Present at 8th Annual Dawson James ConferenceSeptember 21, 2023 | tmcnet.comCYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to ShareholdersSeptember 21, 2023 | finance.yahoo.comCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementAugust 15, 2023 | finance.yahoo.comCyclo Therapeutics Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | benzinga.comCyclo Therapeutics And This Other Penny Stock Insiders Are BuyingJune 12, 2023 | benzinga.comCyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer's DiseaseMay 22, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Cyclo Therapeutics StockMay 15, 2023 | finance.yahoo.comCyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial ResultsMay 2, 2023 | finance.yahoo.comCyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)April 28, 2023 | benzinga.comCyclo Therapeutics Stock (NASDAQ:CYTH), Guidance and ForecastApril 21, 2023 | finance.yahoo.comCyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq RulesMarch 21, 2023 | msn.comCyclo Therapeutics's Return On Capital Employed InsightsMarch 20, 2023 | marketwatch.comCyclo Therapeutics in Talks About Possible CombinationMarch 20, 2023 | finance.yahoo.comCyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial ResultsMarch 15, 2023 | seekingalpha.comCYTH Cyclo Therapeutics, Inc.March 10, 2023 | benzinga.comCyclo Therapeutics Chief Operating Officer Awarded $44K Worth of Stock OptionsMarch 10, 2023 | benzinga.comCyclo Therapeutics Chief Regulatory Officer Awarded $44K Worth of Stock OptionsMarch 10, 2023 | benzinga.comCyclo Therapeutics Board Member Awarded $3K Worth of Stock OptionsJanuary 11, 2023 | barrons.comCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol(R) Cyclo(TM) for the Treatment of Early Alzheimer's DiseaseJanuary 11, 2023 | finance.yahoo.comCyclo Therapeutics Provides Clinical Program Update and Highlights Recent AchievementsJanuary 10, 2023 | finance.yahoo.comCyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch EventJanuary 9, 2023 | benzinga.comCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer's DiseaseJanuary 9, 2023 | finance.yahoo.comCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! CYTH Media Mentions By Week CYTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTH News Sentiment▼0.430.62▲Average Medical News Sentiment CYTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTH Articles This Week▼20▲CYTH Articles Average Week Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VXRT News ATHA News XFOR News OPT News TVGN News CLLS News CRDF News OMGA News ELUT News SGMO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
